Purpose: To investigate the possible role of autoimmune reactions directed against retinal tissue in central serous chorioretinopathy (CSC), by analysing the presence of serum antiretinal antibodies (ARAs) and establishing their clinical relevance. Methods: Sixty-three patients with CSC were included, and clinical characteristics were collected. Serum samples of all patients with CSC, 101 uveitis patients and 60 healthy donors were analysed for the presence of ARAs by indirect immunofluorescence. Furthermore, all CSC serum samples were analysed on Western blot. Correlations between laboratory findings and clinical features of CSC were determined by logistic regression. Results: Antiretinal antibodies (ARAs) were present in 54% of the patients with CSC, in 46% of uveitis patients (p = 0.153) and in 17% of healthy controls (p < 0.001). The majority of ARAs in CSC were directed against photoreceptors (27%), which occurred significantly more often compared to uveitis patients (15%, p = 0.039) and to healthy controls (5%, p = 0.003). No associations between clinical CSC characteristics and the presence of ARAs were found. Conclusion: Serum ARAs are present in more than half of the patients with CSC, and especially, ARAs directed against photoreceptors were detected more frequently compared to both healthy controls and uveitis patients. Further research is warranted to unravel the role of ARAs in the pathogenesis of CSC.
Introduction
Central serous chorioretinopathy (CSC) is a specific and relatively common earlyonset chorioretinal disease that primarily affects the macula. In CSC, a subretinal fluid (SRF) leakage through a dysfunctional retinal pigment epithelium (RPE) leads to detachment of the neuroretina (Gemenetzi et al. 2010; Yannuzzi 2010; Daruich et al. 2015) . A prolonged neuroretinal detachment in the macula causes permanent central visual loss due to photoreceptor atrophy (Gemenetzi et al. 2010; Yannuzzi 2010) . Such a loss of visual acuity (VA), sometimes associated with image distortion and loss of colour and contrast vision, may have a high impact on a patient's personal and professional life. Early diagnosis and treatment is desirable to try to improve the visual outcome and quality of life (Gilbert et al. 1984; Brancato et al. 1987; Levine et al. 1989; Bujarborua 2001; Loo et al. 2002; Otsuka et al. 2002; Wang et al. 2002; Wong et al. 2004; Stewart 2006; Gemenetzi et al. 2010; Daruich et al. 2015) .
The exact pathogenesis of CSC is currently obscure; presumably, CSC occurs due to dysfunction of the RPE with hyperpermeability, swelling and leakage of the underlying choroid (Liew et al. 2013; Daruich et al. 2015) . Moreover, the optimal treatment for CSC is unknown (Wong et al. 2016) . Central serous chorioretinopathy (CSC) is up to six times more common in men (estimated mean annual age-adjusted incidence: 9.9 per 100 000) compared to women (estimated incidence: 1.7 per 100 000; Kitzmann et al. 2008) . Central serous chorioretinopathy (CSC) is associated with the use of steroid containing medication, with odds ratios up to 37.1, as well as with endogenous hypercortisolism (Bouzas et al. 1993; Carvalho-Recchia et al. 2002; Haimovici et al. 2004; Jonas & Kamppeter 2005) . Familial occurrence of CSC has been described, and recent studies have found evidence of genetic associations in patients with CSC, including genetic polymorphisms in the CFH gene, the ARMS2 gene, the C4b gene and the CD5 gene (Jenkins et al. 1967; Yannuzzi 1987; Park et al. 1998; Weenink et al. 2001; Wang et al. 2008; Miki et al. 2014; Schubert et al. 2014; Breukink et al. 2015) .
Although little is known about the exact cause of CSC, a role of the immune system via the complement system has been suggested based on associations found in complementrelated genes. Recent evidence suggests a role for ARAs in uveitis and agerelated macular degeneration (Patel et al. 2005; Morohoshi et al. 2012; Kubicka-Trzaska et al. 2016; Ten Berge et al. 2016) . A systematic study on presence and the possible role of ARAs in CSC is currently lacking.
We hypothesize that damage to the RPE (outer blood retinal barrier) in CSC may result in a secondary formation of ARAs, which may affect the clinical course of CSC. In this study, we set out to investigate the presence of serum ARAs in patients with CSC and to analyse a possible correlation of ARAs with the clinical characteristics of CSC.
Materials and Methods

Patient and data selection
In this study, we included 63 Caucasian patients with chronic CSC who visited the outpatient clinic of the Department of Ophthalmology of the Leiden University Medical Center, Leiden, the Netherlands. The diagnosis of chronic CSC was based on ophthalmic examination and multimodal imaging, including fundoscopy, optical coherence tomography (OCT) using either the spectral-domain optical coherence tomography (SD-OCT) or the Cirrus OCT device, fundus autofluorescence, fluorescein angiography (FA) and indocyanine green angiography. The diagnosis of chronic CSC was based on the presence of all of the following criteria: serous SRF on OCT, ≥1 area of multifocal diffuse leakage or irregular RPE window defects on FA and corresponding hyperfluorescent areas on indocyanine green angiography. Patients diagnosed with acute CSC were excluded from this study, as it is currently unclear if acute CSC and chronic CSC represent a continuum or are separate disease entities. Patients with evidence of other retinal diagnoses, choroidal neovascularization and/or polypoidal choroidal vasculopathy were also excluded. Clinical data of patients with CSC were collected from medical data files and included patient demographics (age, gender and (family) history) and ocular characteristics comprising stage, duration, activity and laterality of CSC, use of steroids or immunosuppressive medications, presence of intraretinal oedema, treatment for CSC and central retinal thickness (distance from the outer part of the ellipsoid zone to the inner part of the internal limiting membrane; CRT). The CRT of the affected eye was selected; if both eyes were affected, the right eye was included. Diffuse CSC was characterized by the presence of >5 disc areas of hyperfluorescent RPE changes or leakage on FA. Serum samples of 101 patients with uveitis (intermediate uveitis, posterior uveitis or panuveitis) were used as disease controls, as a higher prevalence of ARAs in serum in this cohort has been described previously (Ten Berge et al. 2016) . Serum of 60 blood bank donors (gender and age unknown) was used as (presumed) healthy controls. The study adhered to the tenets of the Declaration of Helsinki. Approval of the ethics committee and institutional review board was obtained.
Detection of ARAs using indirect immunofluorescence (IIF)
Initial screening of sera for ARAs was performed as described previously (Ten Berge et al. 2016) . In short, cryosections of primate retinal tissue generated by Euroimmun (Lubeck, Germany) were left unfixed and incubated with 1:100 diluted serum for 30 min at room temperature. Sections were washed in stagnant phosphate-buffered saline (PBS) and incubated with goat antihuman IgG conjugated with fluorescein isothiocyanate (FITC) for 30 min at room temperature. Thereafter, sections were washed in stagnant PBS and embedded. The positive control consisted of retinal tissue incubated with 1:100 diluted serum of an antinuclear antibody (ANA)-positive patient; for the negative controls, we used incubation with PBS and 1:100 diluted serum of a healthy control.
Detection of ANA using IIF All sera showing staining of the retinal nuclear layers (outer/inner nuclear layer, ganglion cell layer) on IIF were subsequently analysed for the presence of ANAs. ANA detection was performed by IIF using HEp-2 cells (Inova, San Diego, CA, USA), as described before (Ten Berge et al. 2016) . In summary, HEp-2 cells were incubated with 1:80 diluted serum for 30 min at room temperature. After washing in PBS with continuous stirring, slides were incubated for another 30 min with FITC-conjugated goat anti-human IgG with propidium iodide (Inova). Subsequently, slides were washed and embedded.
Evaluation of IIF results
All slides were evaluated with a fluorescence microscope (209 magnification) by two independent observers. Specific retinal layers (ganglion cell layer, inner plexiform layer, inner nuclear layer, outer plexiform layer, outer nuclear layer, and rods and cones layer) were evaluated for the presence of fluorescent staining including intensity of the staining. When both ANA (on HEp-2-cells) and ARA (on primate retinal tissue) had an equivalent intensity of staining, a sample was scored as 'unknown' because this combination does not allow a proper discrimination between the presence and absence of ARAs, by possible masking due to ANAs. These samples were excluded from the final analyses.
Western blot analysis
All patients with CSC were evaluated for the presence of ARAs using Western blot analysis. Healthy human retinal protein extract was obtained after retina tissue homogenization in PBS. Tissue fragments were removed by centrifugation, and the supernatant was frozen at À80°C until use. Retinal tissue extract was fractionated by SDS-polyacrylamide gel electrophoresis, and separated proteins were subsequently transferred to nitrocellulose membranes. The membranes were blocked by incubation with 5% non-fat dry milk and incubated with serum of CSC patients or with appropriate control serum at a dilution of 1:100 in 5% non-fat dry milk in Tris-buffered saline (TBS) overnight. After multiple washes with 0.1% TBS, membrane bound human IgG was identified by horseradish peroxidase-conjugated F (ab') 2 goat anti-human IgG (Thermo Fisher Scientific, Waltham, MA, USA) at a dilution of 1:5000 in 5% non-fat dry milk in TBS-Tween. Reactivity was visualized using enhanced chemiluminescence.
Statistics
First, descriptive analyses were performed to obtain information on the characteristics of the patients with CSC. Second, logistic regression with correction for age and gender was employed to evaluate whether the presence of ARAs is associated with CSC. Finally, logistic regression with correction for age and gender was used to identify any clinical characteristics that were possibly associated with the presence of ARAs, p < 0.05 was considered statistically significant. All analyses were performed with SPSS (IBM Corp., Released 2012, IBM SPSS Statistics for Windows, Version 21.0., Armonk, NY, USA).
Results
Patient characteristics
All patient characteristics are shown in Table 1 . A total of 63 chronic patients with CSC (56 male, 7 female), with a mean age of 51 AE 9 years (range, 31-72 years), was included in this study. The median duration of CSC at the time of blood collection was 585 days (range, 3-7832 days). Diffuse CSC was present in 11/62 patients (18%; data not available for one patient). In 38/48 patients with CSC (79%; data not available for 15 patients), SRF was present at the moment of blood collection, indicating active CSC. The mean CRT was 134 AE 37 lm (range, 57-226 lm). Previous to blood collection, no treatment for CSC was given in 35/63 patients (56%), whereas 13/63 patients (21%) had received either micropulse or focal laser treatment and 10/63 patients (16%) had received photodynamic therapy.
ARAs on IIF in patients with CSC
The IIF results are summarized in Table 2 . Positive staining of the retina on IIF was present in 35/63 patients with CSC (56%). After adjustment for retinal staining due to ANA, the presence of ARAs was confirmed in 32/59 patients with CSC (54%). Among different staining patterns observed, staining of the photoreceptors was the most prevalent pattern in patients with CSC (17/63; 27%; Fig. 1 ). Other observed staining patterns in serum of patients with CSC included staining of nuclear layers (N = 8), fluorescence between the inner nuclear layer and the outer plexiform layer (N = 7), fluorescence between the outer nuclear layer and the photoreceptors (N = 3), and/or staining of the inner plexiform layer (N = 2). Nine patients with CSC had a combination of different staining patterns on IIF.
The prevalence of ARAs in patients with CSC was higher than in healthy controls (10/59; 17%; p < 0.001). In addition, staining of the photoreceptors occurred in a lower percentage of healthy controls (5%) compared to patients with CSC (p = 0.003). In patients with uveitis, any positive staining of the retina (after correction for ANA presence) was observed in 39/84 patients (46%), which was not significantly different from patients with CSC (p = 0.153). In contrast, specific staining of the photoreceptors in uveitis patients (15%) was less prevalent compared to patients with CSC (p = 0.039). No significant differences in the prevalence of staining of other specific retinal layers between patients with CSC and the two control groups were observed.
Clinical characteristics of CSC in relation to presence of ARAs on IIF
The presence of ARAs on IIF was higher in the six female patients with CSC (100%) compared to the 57 male patients with CSC (46%; p = 0.024; Table 3 ). Staining of the photoreceptors in the samples of female and male 
ARAs on Western blot in patients with CSC
Multiple ARAs were observed in the majority of patients with CSC (Fig. 2) 
Discussion
We show that serum ARAs were present in 54% of patients with chronic CSC and in 17% of healthy controls. No significant difference in the prevalence of overall ARAs in serum was found between patients with CSC and uveitis patients (46%), although staining of the photoreceptors occurred more often in patients with CSC (27%) than in uveitis patients (15%).
No differences in the presence of ARAs were observed when patients with CSC were subdivided into specific subgroups based on clinical characteristics. The multiple staining patterns on IIF in individual patients with CSC indicate the presence of diverse ARAs, which was confirmed by Western blot analysis. Also, within patients who were solely showing staining of the photoreceptors on IIF, Western blot indicated the presence of diverse antibodies directed against the retina. This suggests that diverse retinal antibodies are associated with photoreceptor staining.
The reason for the higher prevalence of ARAs in CSC, especially those directed against photoreceptors, and their clinical significance is currently not clear. Possibly, chronic retinal damage caused by the presence of SRF accumulation, associated with a breakdown of the RPE (which normally constitutes the outer bloodretinal barrier), may trigger formation of ARAs through an inflammatory reaction of the immune system (Caspi 2010) . In the past, ARAs have been shown in autoimmune retinopathy, in which ARAs are suggested to have pathogenic properties. Elevated serum ARAs were also observed in other chorioretinal diseases (e.g. uveitis, macular degeneration, retinitis pigmentosa) as well as in the healthy population (Kumar et al. 1983; Stanford et al. 1988; Gurne et al. 1991; Heckenlively et al. 1996; Kubicka-Trzaska 2004; Kijlstra et al. 2005; Patel et al. 2005; Patel & Chan 2008; Shimazaki et al. 2008; Morohoshi et al. 2009 Morohoshi et al. , 2012 Nussenblatt et al. 2009 Nussenblatt et al. , 2013 Kubicka-Trzaska et al. 2014; Ten Berge et al. 2016) . Here, an immune response to ocular tissue damage has been previously suggested to play a role in aggravation of the various retinal diseases (Chant et al. 1985; Heckenlively et al. 1996) . Similarly, autoreactive immunological responses have (A) (B) been found in patients with proven infectious uveitis, in which the primary cause (infection) presumably incited the secondary formation of antibodies, possibly due to tissue damage (Whittle et al. 1998) . Interestingly, recent genetic studies in CSC have found an association with genetic variants in the complement system, an essential part of the innate immune system (Miki et al. 2014; de Jong et al. 2015) . However, it is unclear if there is a primary role of the immune system in the pathogenesis of CSC. The mere presence of serum autoantibodies does not necessarily indicate an autoimmune basis of the disease. Moreover, ARAs were not found in all patients and exhibited a wide variety. The presence of ARAs in serum of patients with CSC might be hypothetically explained by their immune predisposition. Central serous chorioretinopathy (CSC) can occur in patients with various immune-mediated diseases including membranoproliferative glomerulonephritis and systemic lupus erythematosus (Shimura et al. 2003; Awan et al. 2008) . It is unclear whether CSC in these patients is only caused by glucocorticoid treatment prescribed for these conditions or whether it is also influenced by the presence of inflammatory disease (Wang et al. 2008) . Another potential systemic mechanism in the development of ARAs could be the mimicry between ocular antigens and microbial proteins, brought up by a previous systemic infection (Adamus & Chan 2002) . However, the presence of antecedent infectious disorders in CSC has not previously been assigned as its cause. A higher prevalence of Helicobacter pylori infections in patients with CSC has been described, although a firm association has never been proven (Mauget-Faysse et al. 2002; Cotticelli et al. 2006; Wong et al. 2016) . Moreover, autoimmune responses would be rather expected in a female-dominated disease. In CSC, particularly men between the age of 25 and 55 are affected, analogous to the phase of life in which highest androgen levels can be detected, suggesting a possible role of this hormone within the development of CSC (Miki et al. 2014; Schubert et al. 2014 ). In our study, the role of the immune system in CSC seemed to be most important in female patients with CSC, as ARAs occurred in all six initially included female patients with CSC. However, after our study was completed, we had the possibility to analyse three extra samples from female patients with CSC. All three samples showed absence of ARAs on IIF, resulting in similar occurrences of ARAs in male and female patients with CSC (Table 3) .
So far it is unclear whether ARAs are involved in the pathogenesis of CSC or whether their presence represents a secondary epiphenomenon. As CSC is mainly a disease of the choroid and RPE, experiments assessing antibodies directed against the choroid and RPE could give more insight to the pathogenesis (Gemenetzi et al. 2010; Yannuzzi 2010; Liew et al. 2013; Daruich et al. 2015) . The assessment of intraocular ARAs might help to clarify the possible pathogenic role of ARAs (Ten Berge et al. 2016) .
The prevalence of ARAs in serum of blood bank donors of 17% is similar to the prevalences of ARAs in healthy controls in previous studies (Chant et al. 1985; Whittle et al. 1998; Heckenlively et al. 1999; Kubicka-Trzaska 2004; Patel et al. 2005; Ten Berge et al. 2016) . One could argue that some of the blood donors might have ocular conditions which could also lead to the formation of ARAs. However, this would not affect our results as we found a difference in the prevalences of ARAs even with our blood bank controls.
In conclusion, serum ARAs are more common in patients with CSC than in healthy controls. No clear association between the presence of ARAs and clinical CSC characteristics could be identified in the current cohort. To unravel the possible involvement of autoimmune reactivity in the pathogenesis of CSC, further research is warranted. 
